-
公开(公告)号：US11147967B2
公开(公告)日：2021-10-19
申请号：US16163811
申请日：2018-10-18
发明人： Lynne E Swanson , Barbara Huibregtse , Bryan A. Clark , Dennis B. Werner , Natalie A. Brill , Michael X. Govea , Umang Anand , William C. Stoffregen
IPC分类号： A61B5/00 , G16H40/63 , A61B5/11 , A61B5/0205 , A61B5/021 , A61B5/024 , A61M1/10 , A61M1/12 , A61N1/36 , A61N1/30 , A61N1/05 , A61N1/375 , A61N1/372
摘要： Various aspects of the present disclosure are directed toward apparatuses, systems, and methods for delivering therapy to an adrenal gland of a patient. The apparatuses, systems, and methods may include a plurality of stimulation elements arranged configured to deliver stimulation energy through at least one of the plurality of stimulation elements to modulate aldosterone levels within the patient.
-
公开(公告)号：US11559355B2
公开(公告)日：2023-01-24
申请号：US16443562
申请日：2019-06-17
摘要： A virtual or augmented reality system is disclosed which is capable of both (i) evaluating prospective implantable neurostimulator patient candidates, and (ii) determining optimal stimulation settings for already-implanted neurostimulation patients. Physiological sensors are included with the system to provide objective measurements relevant to a patient's symptoms, such as pain in a Spinal Cord Stimulation (SCS) system. Such objective measurements are determined during the presentation of various virtual or augmented environments, and can be useful to determining which patients are suitable candidates to consider for implantation. Stimulation settings for already-implanted patients may be adjusted while presenting a virtual or augmented environment to the patient, with objective measurements being determined for each stimulation setting. Such objective measurements can then be used to determine optimal stimulation settings for the patient.
-
公开(公告)号：US20230121855A1
公开(公告)日：2023-04-20
申请号：US18068984
申请日：2022-12-20
摘要： A virtual or augmented reality system is disclosed which is capable of both (i) evaluating prospective implantable neurostimulator patient candidates, and (ii) determining optimal stimulation settings for already-implanted neurostimulation patients. Physiological sensors are included with the system to provide objective measurements relevant to a patient's symptoms, such as pain in a Spinal Cord Stimulation (SCS) system. Such objective measurements are determined during the presentation of various virtual or augmented environments, and can be useful to determining which patients are suitable candidates to consider for implantation. Stimulation settings for already-implanted patients may be adjusted while presenting a virtual or augmented environment to the patient, with objective measurements being determined for each stimulation setting. Such objective measurements can then be used to determine optimal stimulation settings for the patient.
-
公开(公告)号：US20200030035A1
公开(公告)日：2020-01-30
申请号：US16443562
申请日：2019-06-17
IPC分类号： A61B34/10 , A61B5/0205 , A61B5/16 , A61M21/00 , A61N1/36
摘要： A virtual or augmented reality system is disclosed which is capable of both (i) evaluating prospective implantable neurostimulator patient candidates, and (ii) determining optimal stimulation settings for already-implanted neurostimulation patients. Physiological sensors are included with the system to provide objective measurements relevant to a patient's symptoms, such as pain in a Spinal Cord Stimulation (SCS) system. Such objective measurements are determined during the presentation of various virtual or augmented environments, and can be useful to determining which patients are suitable candidates to consider for implantation. Stimulation settings for already-implanted patients may be adjusted while presenting a virtual or augmented environment to the patient, with objective measurements being determined for each stimulation setting. Such objective measurements can then be used to determine optimal stimulation settings for the patient.
-
公开(公告)号：US10441788B2
公开(公告)日：2019-10-15
申请号：US15683750
申请日：2017-08-22
发明人： Lynne E. Swanson , William C. Stoffregen , Bryan A. Clark , Michael X. Govea , Dennis B. Werner , Natalie A. Brill , Pramodsingh H. Thakur
IPC分类号： A61N1/36 , A61B5/00 , A61B1/05 , A61F7/00 , A61F7/12 , A61N1/05 , A61B5/01 , A61B5/0215 , A61B5/024 , A61B5/029 , A61B5/08 , A61B5/145 , A61B5/1473
摘要： Aspects of the present disclosure are directed toward apparatuses, systems, and methods for delivering therapy to an adrenal gland of a patient. The apparatuses, systems, and methods may include a lead body that attaches to a portion of the adrenal gland of the patient; and a plurality of electrodes arranged along the lead body. In addition, one or more of the plurality of electrodes may deliver stimulation energy to modulate catecholamine release from chromaffin cells within the adrenal gland.
-
公开(公告)号：US20180104480A1
公开(公告)日：2018-04-19
申请号：US15847561
申请日：2017-12-19
发明人： Lynne E. Swanson , William C. Stoffregen , Bryan A. Clark , Michael X. Govea , Dennis B. Werner , Natalie A. Brill , Pramodsingh H. Thakur
CPC分类号： A61N1/0556 , A61B5/021 , A61B5/02125 , A61B5/1118 , A61B5/4227 , A61B5/4836 , A61B2562/0219 , A61F7/12 , A61F2007/0075 , A61F2007/126 , A61N1/0553 , A61N1/0558 , A61N1/36031 , A61N1/3606 , A61N1/36139 , A61N1/36171 , A61N1/36175
摘要： Aspects of the present disclosure are directed toward apparatuses, systems, and methods for delivering therapy to an adrenal gland of a patient. The apparatuses, systems, and methods may include a housing and a plurality of electrodes arranged with the housing. In addition, one or more of the plurality of electrodes may deliver stimulation energy to modulate L-dopa release.
-
公开(公告)号：US20180056071A1
公开(公告)日：2018-03-01
申请号：US15683773
申请日：2017-08-22
发明人： Lynne E. Swanson , Bryan A. Clark , Dennis B. Werner , William C. Stoffregen , Michael X. Govea , Natalie A. Brill
CPC分类号： A61N1/36114 , A61N1/0551 , A61N1/36007 , A61N1/36017 , A61N1/3605 , A61N1/36121 , A61N1/37205 , A61N1/3756
摘要： Aspects of the present disclosure are directed towards apparatuses, systems, and methods that include at least one implantable medical device. The implantable medical device may include a leadless body portion configured to engage an adrenal gland of a patient and at least one electrode, arranged within the leadless body portion, configured to deliver stimulation energy to modulate catecholamine release from chromaffin cells within the adrenal gland.
-
公开(公告)号：US12089899B2
公开(公告)日：2024-09-17
申请号：US18068984
申请日：2022-12-20
CPC分类号： A61B34/10 , A61N1/36062 , A61B5/0075 , A61B5/11 , A61B5/1468 , A61B5/318 , A61B5/369
摘要： A virtual or augmented reality system is disclosed which is capable of both (i) evaluating prospective implantable neurostimulator patient candidates, and (ii) determining optimal stimulation settings for already-implanted neurostimulation patients. Physiological sensors are included with the system to provide objective measurements relevant to a patient's symptoms, such as pain in a Spinal Cord Stimulation (SCS) system. Such objective measurements are determined during the presentation of various virtual or augmented environments, and can be useful to determining which patients are suitable candidates to consider for implantation. Stimulation settings for already-implanted patients may be adjusted while presenting a virtual or augmented environment to the patient, with objective measurements being determined for each stimulation setting. Such objective measurements can then be used to determine optimal stimulation settings for the patient.
-
公开(公告)号：US10583286B2
公开(公告)日：2020-03-10
申请号：US15847561
申请日：2017-12-19
发明人： Lynne E. Swanson , William C. Stoffregen , Bryan A. Clark , Michael X. Govea , Dennis B. Werner , Natalie A. Brill , Pramodsingh H. Thakur
摘要： Aspects of the present disclosure are directed toward apparatuses, systems, and methods for delivering therapy to an adrenal gland of a patient. The apparatuses, systems, and methods may include a housing and a plurality of electrodes arranged with the housing. In addition, one or more of the plurality of electrodes may deliver stimulation energy to modulate L-dopa release.
-
公开(公告)号：US20190111253A1
公开(公告)日：2019-04-18
申请号：US16163811
申请日：2018-10-18
发明人： Lynne E Swanson , Barbara Huibregtse , Bryan A. Clark , Dennis B. Werner , Natalie A. Brill , Michael X. Govea , Umang Anand , William C. Stoffregen
摘要： Various aspects of the present disclosure are directed toward apparatuses, systems, and methods for delivering therapy to an adrenal gland of a patient. The apparatuses, systems, and methods may include a plurality of stimulation elements arranged configured to deliver stimulation energy through at least one of the plurality of stimulation elements to modulate aldosterone levels within the patient.
-
-
-
-
-
-
-
-
-
搜索结果
12 条记录 (耗时 0.02 秒)
